Is Rozebalamin (methylcobalamin) on the market? How to buy?

Rozebalamin (methylcobalamin) has been launched in Japan in 2024 and has received production and marketing approval for the treatment of amyotrophic lateral sclerosis (ALS). Its launch brings new treatment options to ALS patients, aiming to improve their quality of life by slowing the progression of the disease and improving neurological function. The drug is produced by Eisai Co., Ltd. As an active vitamin B12 derivative with neuroprotective effects, Rozebalamin is also widely used in the treatment of other neuropathies and vitamin B12 deficiency-related diseases.

In Japan,Rozebalamin (methylcobalamin) can be purchased through hospitals or pharmacies, usually with a doctor's prescription. Patients first need to be evaluated by a medical institution to determine whether they are suitable for using this drug, especially for patients with neuropathy caused by ALS or vitamin B12 deficiency, which are usually treated under the guidance of a doctor. When purchasing, patients need to bring a doctor's prescription, and the hospital or pharmacy will provide the medicine according to the specific condition.

If you are a patient outside Japan and want to purchase Rozebalamin, the drug has not yet been approved for marketing in other countries, so you need to purchase it through overseas drug purchase channels. Patients can purchase this drug through legal international drug purchasing services or multinational pharmacy platforms, but when making cross-border purchases, they need to pay special attention to the legality and safety of the drug. At the same time, since medicines may involve higher costs, patients are advised to consult a professional doctor before purchasing to ensure correct medication use.

For patients who wish to pay for their medicines through medical insurance, Japan has approvedRozebalamin to be included in the payment scope of medical insurance, but the specific reimbursement ratio and conditions may vary depending on the specific situation of the patient. Patients should consult their hospital or pharmacy about the relevant policies and procedures for medical insurance reimbursement when purchasing to ensure that they can obtain the medical protection they deserve.

xa0

References:

[1]https://pins.japic.or.jp/pdf/newPINS/00071540.pdf

[2]https://www.eisai.com/news/2024/news202487.html